During therapy, some cancer cells evolve to escape elimination. Newer anticancer drugs that can overcome this resistance are ...

Pancreatic cancer accounts for about 3% of all cancers in the United States and about 7% of all cancer deaths, the American Society of Cancer reports. Here's what to know about the disease.

The American Cancer Society estimates that 67,400 Americans will be diagnosed with pancreatic cancer this year and nearly 52,000 will die from the disease. Primary Menu Sections.

A Memorial Sloan Kettering phase 1 clinical trial revealed an immune response in some pancreatic cancer patients. Study co-author Dr. Vinod Balachandran talks about the impact on future cancer care.

When used alongside the existing CA 19-9 test, it was able to diagnose early-stage pancreatic cancer with 85% accuracy. Stock image of a person getting blood drawn. Getty ...

The team then tested the approach on two patients whose pancreatic tumors had resisted earlier treatments (NCT05227326), finding that the individuals experienced up to a 49% shrinkage in their ...

FRIDAY, Feb. 21, 2025 (HealthDay News) -- Adding a personalized mRNA vaccine to standard treatment could offer new hope for pancreatic cancer patients, a small yet promising study from Memorial ...

In pancreatic cancer, a race against time Date: April 2, 2025 Source: Cold Spring Harbor Laboratory Summary: Scientists have found a way to 'intercept' pancreatic cancer.

“There are three main reasons pancreatic cancer is so deadly,” explains Conan Kinsey, MD, PhD, a physician-scientist who treats patients with pancreatic cancer at Huntsman Cancer Institute at the ...

There was an unexpected rise in pancreatic cancer among young people in the United States from 2000 to 2018. The illness can be untreatable by the time it is discovered, a death sentence.

In the study, researchers wanted to know what allowed cells to survive in one place instead of the other. To do this, they analyzed data from MetMap, a project at the Broad Institute, an independent ...